ERIN SAITO, PHD, MSC
Erin Saito is the President and CEO of 3RT Innovations. Dr. Saito brings a broad background in science and technology, as well as experience in clinical research and preclinical drug development. At 3RT Innovations, Dr. Saito's primary responsibility is for the scientific success of any proposed research projects, working closely with collaborators to develop projects, setting research goals and priorities, and identifying therapeutic approaches and targets.
BRIAN SPENCER, PHD
Brian Spencer serves at the Scientific Advisor for 3RT Innovations. Dr. Spencer is an original inventor on the patent for the single chain antibody and brings considerable expertise in neurodegeneration, viral vectors, gene and protein delivery to neurons and other cells, and in vivo culture conditions. Dr. Spencer is currently also a Senior Scientist at Novartis Gene Therapies.
AARON MCMURTRAY, MD, PHD
Aaron McMurtray is the Medical Director for 3RT Innovations. Dr. McMurtray is a leading expert in the field of neurodegenerative diseases including Alzheimer's disease and chronic traumatic encephalopathy. Dr. McMurtray is a board certified neurologist and the Medical Director for Dementia Care at the University of California, Los Angeles.